These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 8544412

  • 21. Relation between band 3 red blood cell protein and transmembrane oxalate flux in stone formers.
    Baggio B, Gambaro G, Borsatti A, Clari G, Moret V.
    Lancet; 1984 Jul 28; 2(8396):223-4. PubMed ID: 6146776
    [No Abstract] [Full Text] [Related]

  • 22. Red blood cell transmembrane oxalate flux in calcium-oxalate nephrolithiasis.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A.
    Contrib Nephrol; 1985 Jul 28; 49():118-21. PubMed ID: 3830561
    [No Abstract] [Full Text] [Related]

  • 23. Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.
    Marangella M, Fruttero B, Bruno M, Linari F.
    Clin Sci (Lond); 1982 Oct 28; 63(4):381-5. PubMed ID: 7105633
    [Abstract] [Full Text] [Related]

  • 24. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.
    Bergsland KJ, Zisman AL, Asplin JR, Worcester EM, Coe FL.
    Am J Physiol Renal Physiol; 2011 Feb 28; 300(2):F311-8. PubMed ID: 21123489
    [Abstract] [Full Text] [Related]

  • 25. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ.
    Scand J Urol Nephrol; 1999 Dec 28; 33(6):368-71. PubMed ID: 10636575
    [Abstract] [Full Text] [Related]

  • 26. Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: clinical implications in calcium oxalate nephrolithiasis.
    Baggio B, Priante G, Brunati AM, Clari G, Bordin L.
    J Am Soc Nephrol; 1999 Nov 28; 10 Suppl 14():S381-4. PubMed ID: 10541268
    [Abstract] [Full Text] [Related]

  • 27. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 28. An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Tenconi R, Clementi M, Borsatti A.
    N Engl J Med; 1986 Mar 06; 314(10):599-604. PubMed ID: 3945245
    [Abstract] [Full Text] [Related]

  • 29. Pathogenesis of idiopathic calcium nephrolithiasis: update 1997.
    Baggio B, Plebani M, Gambaro G.
    Crit Rev Clin Lab Sci; 1998 Apr 06; 35(2):153-87. PubMed ID: 9592625
    [Abstract] [Full Text] [Related]

  • 30. Intestinal and renal handling of oxalate loads in normal individuals and stone formers.
    Knight J, Holmes RP, Assimos DG.
    Urol Res; 2007 Jun 06; 35(3):111-7. PubMed ID: 17431604
    [Abstract] [Full Text] [Related]

  • 31. Oxalate status in stone-formers. Two distinct hyperoxaluric entities.
    Hatch M.
    Urol Res; 1993 Jan 06; 21(1):55-9. PubMed ID: 8456539
    [Abstract] [Full Text] [Related]

  • 32. Oxalate in renal stone disease: the terminal metabolite that just won't go away.
    Marengo SR, Romani AM.
    Nat Clin Pract Nephrol; 2008 Jul 06; 4(7):368-77. PubMed ID: 18523430
    [Abstract] [Full Text] [Related]

  • 33. Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers.
    Messa P, Londero D, Massarino F, Paganin L, Mioni G, Zattoni F, Cannella G.
    Nephrol Dial Transplant; 2000 Sep 06; 15(9):1388-93. PubMed ID: 10978396
    [Abstract] [Full Text] [Related]

  • 34. Importance of erythrocyte band III anion transporter (SLC4A1) on oxalate clearance of calcium oxalate monohydrate stone-formering patients vs. normal controls.
    Oehlschläger S, Fuessel S, Meye A, Herrmann J, Lotzkat U, Froehner M, Albrecht S, Wirth MP.
    Urology; 2011 Jan 06; 77(1):250.e1-5. PubMed ID: 20947140
    [Abstract] [Full Text] [Related]

  • 35. [Oxalate influx rate in red blood cells in calcium oxalate nephrolithiasis].
    Kato T, Yamakawa K, Kawamura J.
    Hinyokika Kiyo; 1991 Aug 06; 37(8):837-44. PubMed ID: 1957725
    [Abstract] [Full Text] [Related]

  • 36. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
    Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP.
    Br J Urol; 1991 Nov 06; 68(5):454-8. PubMed ID: 1747716
    [Abstract] [Full Text] [Related]

  • 37. Kinetics of early time calcium oxalate nephrolithiasis.
    Jordan WR, Finlayson B, Luxenberg M.
    Invest Urol; 1978 May 06; 15(6):465-8. PubMed ID: 649295
    [Abstract] [Full Text] [Related]

  • 38. Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis.
    Baggio B, Gambaro G, Marchini F, Vincenti M, Ceolotto G, Pessina AC, Semplicini A.
    Clin Sci (Lond); 1994 Mar 06; 86(3):239-43. PubMed ID: 8156732
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B, Gambaro G, Favaro S, Borsatti A.
    Nephron; 1983 Mar 06; 35(1):11-4. PubMed ID: 6888620
    [Abstract] [Full Text] [Related]

  • 40. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.
    Ma MC, Chen YS, Huang HS.
    Urology; 2014 Feb 06; 83(2):510.e9-17. PubMed ID: 24360074
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.